Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
mFCuu08RY6rAb8sZ